Autopsy report · NCT00775268
18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma
Cause of deathNo reason given
Life of this trial
- Ran for about 6 years 1 month before it stopped.
- 31 participants enrolled.
- Results were posted on the registry 6 years 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- National Cancer Institute (NCI)
- Sponsor type
- US National Institutes of Health
- Conditions
- Lymphoma
- Interventions
- Biopsy; fluorodeoxyglucose F 18 Positron Emission Tomography and computed tomography; [3'-deoxy-3'-[F-18] fluorothymidine; computed tomography; fine-needle aspiration
- Participants
- 31
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.